Leuprolide Completed Phase 2 Trials for Adenocarcinoma, Prostate / Stage IV Prostate Cancer / Recurrent Prostate Carcinoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01120236Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer